PARP1 promotes NLRP3 activation via blocking TFEB-mediated autophagy in rotenone-induced neurodegeneration

He Zhang1, Zhefan Xie2, Yongming Peng1

  • 1Department of Preventive Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, PR China; Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan 523808, PR China.

Insights

PARP1 overactivation by the pesticide rotenone impairs autophagy and triggers inflammation, increasing Parkinson's disease risk. Inhibiting PARP1 protects neurons by restoring autophagy and reducing inflammation.

Area of Science:

  • Neuroscience
  • Toxicology
  • Molecular Biology

Background:

  • Rotenone pesticide exposure is linked to dopaminergic neuron loss and Parkinson's disease (PD).
  • The roles of PARP1, neuroinflammation, and autophagy dysfunction in rotenone-induced neurodegeneration are not fully understood.

Purpose of the Study:

  • To investigate the role of PARP1 in rotenone-induced neuroinflammation and autophagy dysfunction.
  • To explore the potential of PARP1 inhibition as a therapeutic strategy for rotenone-induced neurodegeneration.

Main Methods:

  • Utilized rotenone models to induce neurodegeneration.
  • Assessed the impact of PARP1 activation and inhibition on autophagy and NLRP3-mediated inflammation.
  • Investigated the interaction between PARP1 and TFEB (Transcription Factor EB).

Main Results:

  • Rotenone exposure led to PARP1 overactivation, causing autophagy dysfunction and NLRP3-driven inflammation.
  • PARP1 inhibition reduced NLRP3 inflammation, an effect dependent on TFEB.
  • PARP1 poly(ADP-ribosyl)ated TFEB, inhibiting autophagy and promoting neuroinflammation.
  • PARP1 inhibition rescued rotenone-induced dopaminergic neuron loss.

Conclusions:

  • PARP1 exacerbates rotenone-induced neurodegeneration by inhibiting autophagy via TFEB poly(ADP-ribosyl)ation and promoting NLRP3 inflammation.
  • Targeting the PARP1-TFEB-NLRP3 signaling pathway presents a promising therapeutic avenue for Parkinson's disease and related neurodegenerative conditions.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K